Synchron LX20 Clinical Systems, Creatinine Test Systems
Alkaline Picrate, Colorimetry, Creatinine. 510(k) K071277, from Beckman Coulter, Inc. (Brea, CA). Product code CGX, class 2.
As of Nov 17, 2026, K071277 is an FDA 510(k) held by Beckman Coulter, Inc., substantially equivalent on Jun 1, 2007 after 25 days, with 1 recall tied to it in FDA's recall database.
- Substantially equivalent: Jun 1, 2007
- Review time: 25 days
- Recalls: 1
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Beckman Coulter AQUA CAL 1, 2, and 3 are intended for use on SYNCHRON LX® and UniCel® DxC Systems for the calibration of Sodium, Potassium, Chloride, Urea Nitrogen, Urea, Glucose Creatinine, Calcium, Carbon Dioxide, and Phosphorus.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Synchron Lx 20 Clinical Chemistry System, Synchron Lx Albumin Reagent, Synchron Lx…K965240 · Beckman Instruments, Inc. · Mar 10, 1997
Recalls
Recalls FDA ties to K071277, newest first; each opens FDA's recall record| Started | Reason | Status |
|---|---|---|
| May 15, 2017 | Z-2730-2017The firm identified a negative shift of 5mmol/L for sodium recovery in Synchron Control Level 3 when calibrated with AQUA Cal 1. | Terminated |
Other CGX Clearances
The newest 510(k)s for the same product code; their median review was 236 days; see every CGX device- Tru Kidney Health Test Panel; Tru AnalyzerK251058 · Truvian Health · Nov 26, 2025
- Atellica® CH Creatinine_3 (Crea3)K242685 · Siemens Healthcare Diagnostics, Inc. · Dec 4, 2024
- Creatinine2K210452 · Abbott Ireland Diagnostics Division · Mar 22, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- May 7, 2007
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files